Evidence map›Paper›PMID 30697344›Full record

ArticleEvolutionary applications2019

Evolution of the exclusively human pathogen

Corinna S Landig, Ashley Hazel, Benjamin P Kellman, Jerry J Fong, Flavio Schwarz, Sarika Agarwal, Nissi Varki, Paola Massari, Nathan E Lewis, Sanjay Ram and 1 more

Open access · goldAbstract read
In one paragraph

Article in Evolutionary applications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. mBio · 2024
    Article
  9. Article
  10. bioRxiv : the preprint server for biology · 2024
    Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Mechanisms of host manipulation byFrontiers in microbiology · 2023
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Corinna S LandigGlycobiology Research and Training Center University of California, San Diego La Jolla California.
Ashley HazelDepartment of Earth System Science Stanford University Stanford California.
Benjamin P KellmanDepartment of Pediatrics University of California, San Diego La Jolla California.
Jerry J FongGlycobiology Research and Training Center University of California, San Diego La Jolla California.
Flavio SchwarzGlycobiology Research and Training Center University of California, San Diego La Jolla California.
Sarika AgarwalDepartment of Medicine University of Massachusetts Medical School Worcester Massachusetts.
Nissi VarkiGlycobiology Research and Training Center University of California, San Diego La Jolla California.
Paola MassariDepartment of Immunology Tufts University School of Medicine Boston Massachusetts.
Nathan E LewisDepartment of Pediatrics University of California, San Diego La Jolla California.
Sanjay RamDepartment of Medicine University of Massachusetts Medical School Worcester Massachusetts.
Ajit VarkiGlycobiology Research and Training Center University of California, San Diego La Jolla California.ORCID https://orcid.org/0000-0002-2206-975X
University of California San Diego · USUniversity of Massachusetts Chan Medical School · USFoundation Center · USStanford University · USTufts University · US

Funding

Siglec Modulation of Inflammatory ResponsesP01HL107150 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LE, DZUNG T · 2011 to 2017
$18.0M
BIOSYNTHESIS AND REGULATION OF SUBSTITUTED SIALIC ACIDSR01GM032373 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VARKI, AJIT P · 1985 to 2022
$6.9M
Novel immunotherapeutics against multidrug-resistant Neisseria gonorrhoeaR01AI132296 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RAM, SANJAY, RICE, PETER A. · 2017 to 2021
$5.5M
Unraveling the mammalian secretory pathway through systems biology and algorithm developmentR35GM119850 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LEWIS, NATHAN ENOCH · 2016 to 2025
$4.3M
Immune defenses against Neisseria gonorrhoeaeR01AI114790 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RAM, SANJAY, RICE, PETER A. · 2015 to 2019
$3.1M
Vaccines and Immunotherapeutics against gonorrhea in the contex of Chlamydia coU01AI118161 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RAM, SANJAY · 2014 to 2017
$2.0M
NHLBI NIH HHS P01 HL107150NIAID NIH HHS R01 AI114790NIAID NIH HHS R01 AI132296NIAID NIH HHS U01 AI118161NIGMS NIH HHS R01 GM032373NIGMS NIH HHS R35 GM119850
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

disease biologyevolutionary medicinegonorrheamicrobial biologypolymorphismpopulation geneticssialic acidSiglecs

Identifiers

PMID30697344
PMCPMC6346652
OpenAlexW2902419245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.